FY2025 Earnings Estimate for Jushi Issued By Ventum Cap Mkts

Jushi Holdings Inc. (OTCMKTS:JUSHF) – Analysts at Ventum Cap Mkts reduced their FY2025 EPS estimates for Jushi in a note issued to investors on Wednesday, November 5th. Ventum Cap Mkts analyst A. Semple now anticipates that the company will post earnings of ($0.29) per share for the year, down from their previous estimate of ($0.24). The consensus estimate for Jushi’s current full-year earnings is ($0.23) per share. Ventum Cap Mkts also issued estimates for Jushi’s FY2026 earnings at ($0.22) EPS.

Jushi (OTCMKTS:JUSHF) last issued its earnings results on Tuesday, November 4th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.07). The company had revenue of $65.68 million during the quarter, compared to the consensus estimate of $66.67 million.

Separately, Atb Cap Markets upgraded shares of Jushi from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, Jushi presently has an average rating of “Strong Buy”.

Jushi Stock Performance

Shares of JUSHF stock opened at $0.55 on Friday. Jushi has a fifty-two week low of $0.22 and a fifty-two week high of $0.98. The firm has a market capitalization of $107.91 million, a PE ratio of -1.66 and a beta of -1.01. The stock’s 50-day simple moving average is $0.71 and its 200-day simple moving average is $0.52.

About Jushi

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.